Device Trial Radar · NCT06474845
Efficacy of the T-Control® Catheter Compared to the Foley-type Catheter in Patients With Long-term Catheterization
Last checked: Nov 21, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
12
Actual
Start
Feb 10, 2024
Primary completion
May 1, 2026
Study completion Sep 1, 2026
Sponsor
- Lead sponsor
- Rethink Medical SLNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Evidenze CRO; Centro para el Desarrollo Tecnológico y la Innovación (CDTI), Spain
- First posted
- Jun 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the new urinary catheter T-Control® allows a reduction in infections associated with urinary catheters and a better quality of life of urinary catheter patients compared to the conventional Foley-type catheter (the currently used in clinical practice). It will also learn about the safety profile of the T-Control® catheter and its cost-effectiveness. The main questions it aims to answer are: Does the T-Control® catheter lower the number of infections of the patients who need long-term catheterization? Does he T-Control® catheter implies a better perceived quality of life of long-term catheterization patients? Participants will: Be catheterized with T-Control® or Foley catheter. Visit the clinic after 4 weeks for checkups, fullfill questionnaires and tests. Keep a diary of their symptoms and adverse events related to the catheter.
Conditions
- Catheter; Infection (Indwelling Catheter)
- Quality of Life
- Catheter Related Complication
Interventions
T-Control® catheterDevice
Patients will be catheterized with T-Control® for 4 weeks
Foley-type catheterDevice
Patients will be catheterized with a conventional Foley-type catheter for 4 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Catheter-Associated Urinary Tract Infections (symptomatic and asymptomatic)Time frame: 4 weeks
1 more outcomes with a free account
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Prof. Doutor Fernando Fonseca Hospital
Amadora, Portugal
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.